Price:
Rs. 16,150.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: M0023
Frequently Asked Questions (FAQ's):
What does this test include?
Detection of RET gene mutations linked to Medullary Thyroid Carcinoma using PCR-based analysis at Metropolis Healthcare.
How does Metropolis Healthcare perform this test?
The test uses advanced molecular diagnostics and PCR to analyze genetic variants in EDTA blood samples.
Who should take this test?
Patients diagnosed with or suspected of having MTC, individuals with a family history of MTC or MEN2 syndrome, and those requiring genetic risk assessment.
Why is mutation detection important?
It helps determine hereditary risk, supports early treatment decisions, and guides preventive screening for relatives.
Is fasting required for this test?
No fasting is necessary for the test.
How long does Metropolis Healthcare take to deliver results?
Results are typically available within a few working days depending on testing complexity.
Can this test help in treatment planning?
Yes, identifying gene mutations can influence surgical decisions, targeted therapy options, and long-term monitoring strategies.
Is genetic counseling recommended?
Yes, Metropolis Healthcare recommends counseling for patients and families to understand implications and preventive measures